Projects & Events
20 years of research on antibodies become a competitive industrial activity
Mediapharma s.r.l., an italian spin-off supported by INNOVA's seed capital company, INVENT s.a.s, successfully brings the results of 20 years of research on monoclonal antibodies to the pharmaceutical market, a breakthrough for the diagnosis and cancer treatment.
Listen to the interview of Professor Iacobelli transmitted on RAI3 Leonardo News on 25-01-2010 (in italian):
Press Coverage
Publications
Plan and manage a science park in the Mediterranean", a guidebook for decision makers
This guidebook provides science park decision makers with a number of
tools helping them manage a park.
Read more
See all our publications
